Older Minnesotans who have been cleared for COVID-19 booster shots are feeling relief and rushing to pharmacies in hopes of beating back the pandemic's resurgent threat.
Nursing home residents want to avoid last year's restrictive policies for stopping the spread that left them confined to their rooms.
Those who've watched friends and family suffer breakthrough infections after being immunized have concerns over waning protection from their vaccines. Others are focused on maintaining safe connections with grandchildren and the degree of normalcy they've found with immunizations.
Yet for now, the relief is confined to those who were immunized with vaccine made by Pfizer, since regulators have not cleared boosters for those who received COVID-19 vaccines from manufacturers Moderna or Johnson & Johnson.
"I think there's going to be some frustration until they make some decisions [about the other vaccines]," said Laura Schwartzwald, owner of GuidePoint Pharmacy in Brainerd.
"I'm pretty sure that several people are going to be quite relieved and others are going to be a little bit anxious," she said. "I'm hopeful that we're going to get some guidance on ... third doses for Moderna and second doses for Johnson & Johnson because some of the data is coming in."
Federal health officials last week said boosters for the Pfizer vaccine should be offered to people 65 and older, long-term care residents and those ages 50 to 64 with certain underlying health problems. The additional dose would be given once patients are at least six months past their second Pfizer shot.
People ages 18 to 49 with health conditions that increase their COVID-19 risk may also receive boosters, depending on their individual risks and benefits, the Centers for Disease Control and Prevention announced Thursday. The CDC said adults under age 65 at greater risk for COVID-19 exposure and transmission due to their occupation or workplace setting may be offered the Pfizer booster, as well.